DMAA (Drugs Made In America Acquisition) Institutional Ownership: 94.69% (As of Jul. 26, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

DMAA Drugs Made In America Acquisition Corp DMAA
14 GF Score
Price $10.70
! 1 Warning Sign
View Full Analysis

What is Drugs Made In America Acquisition Institutional Ownership?

Drugs Made In America Acquisition DMAA +0.09% 14 Institutional Ownership is 94.69% as of Jul. 26, 2026. GuruFocus rates DMAA with a GF Score™ of 14/100. The stock has 1 warning sign investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Drugs Made In America Acquisition's institutional ownership is 94.69%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Drugs Made In America Acquisition's Insider Ownership is 1.19%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Drugs Made In America Acquisition's Float Percentage Of Total Shares Outstanding is 81.50%.

Drugs Made In America Acquisition Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Drugs Made In America Acquisition's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Drugs Made In America Acquisition Institutional Ownership Chart

Drugs Made In America Acquisition Historical Data

The historical data trend for Drugs Made In America Acquisition can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 13.78 13.76 13.76 22.49 22.51 22.51 22.61 22.61 30.17 29.97
DMAA
14GF Score
Drugs Made In America Acquisition Corp DMAA
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Drugs Made In America Acquisition Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 94.69% mean?
Drugs Made In America Acquisition (DMAA) has a Institutional Ownership of 94.69% as of Jul. 26, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Drugs Made In America Acquisition and its competitors.
Is Drugs Made In America Acquisition's Institutional Ownership too high?
Drugs Made In America Acquisition's current Institutional Ownership is 94.69%. Overall, Drugs Made In America Acquisition has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Drugs Made In America Acquisition's Institutional Ownership compare to PLMK and TRGS?
Drugs Made In America Acquisition's Institutional Ownership of 94.69% can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Diversified Financial Services company?
A good Institutional Ownership depends on the Diversified Financial Services industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Drugs Made In America Acquisition and its competitors. Drugs Made In America Acquisition's current Institutional Ownership is 94.69%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Drugs Made In America Acquisition stock overvalued right now?
Drugs Made In America Acquisition (DMAA) has a current Institutional Ownership of 94.69%. The current Institutional Ownership is 94.69%. Drugs Made In America Acquisition's overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Drugs Made In America Acquisition (DMAA), the current Institutional Ownership is 94.69% as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Drugs Made In America Acquisition Business Description

Address 420 Lexington Avenue, Suite 1402, New York, NY, USA, 10170
Drugs Made In America Acquisition Corp is a blank check company.
14GF Score

Get the complete analysis for DMAA

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$10.70
Price